The Limited Times

Now you can see non-English news...

The Province will choose between combining vaccines or waiting for the second component of Sputnik

2021-08-03T12:30:38.565Z


This Tuesday, the efficacy results of the combination of Sputnik V with AstraZeneca and Sinopharm will be known.


08/03/2021 9:16 AM

  • Clarín.com

  • Society

Updated 08/03/2021 9:16 AM

A few hours after the first results of the efficacy trials of the combination of the Sputnik V vaccine with those of AstraZeneca and Sinopharm are known, the Buenos Aires Minister of Health, Nicolás Kreplak, announced on Tuesday that, if the expected efficacy is confirmed, Those who have received the first dose of the Russian formula 

may choose to combine vaccines to complete their schedule

or wait for the arrival of doses of component 2 of Sputnik.

"We are finishing the studies, surely today, tonight, the first report will be closed and tomorrow there will be a press conference.

We already know that safety is good

, mixing vaccines has no further complications. Today we will see antibodies. We will now have results. to combine Sputnik with AstraZeneca and Sinopharm, and security to combine Sputnik with Moderna ", Kreplak said in an interview with

El Uncover

.

And he added: "In two more days we will also be able to have Sputnik efficacy studies with Moderna."

According to the official, if the results are as expected, in the next few hours they would begin to summon the people who received a single dose of Sputnik V, in some cases, four months ago.

"We are going to invite people to receive the vaccine with what we have, component 2 or the combinations that have demonstrated safety and efficacy, and

whoever does not want to will be able to wait,

" Kreplak said.

News in development.

LGP


Source: clarin

All life articles on 2021-08-03

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.